by Brandon Tudor | Oct 11, 2025 | Uncategorized
FROM THE RECENT PAPER regarding diagnostic testing and weight loss medication:”Conclusion: Non-Invasive Tests (NITs) may be used for assessing a treatment response in patients with MASH. Further studies should confirm the treatment effect of NITs and evaluate...
by Brandon Tudor | Oct 9, 2025 | Uncategorized
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (“Akero”) (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today...
by Brandon Tudor | Oct 6, 2025 | Uncategorized
This October 2025 paper, titled “Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 Study,” has this summary–“In this large, population-based...
by Brandon Tudor | Oct 4, 2025 | Uncategorized
More than 100 million people in the U.S. have some form of liver disease, according to the American Liver Foundation. Liver disease diagnoses can include metabolic dysfunction-associated steatotic liver disease (formerly known as non-alcoholic fatty liver disease),...
by Brandon Tudor | Sep 30, 2025 | Uncategorized
The liver plays a vital role that affects the whole body. It is common to see clinical findings throughout the body, from head to foot; the signs of liver disease are for the most part to be found OUTSIDE the abdomen. Liver disease manifests not just in the abdomen,...
